9 Nov 2022 , 06:05 PM
Net profit of Novartis India rose 161.40% to Rs 18.35 crore in the quarter ended September 2022 as against Rs 7.02 crore during the previous quarter ended September 2021. Sales declined 2.83% to Rs 101.52 crore in the quarter ended September 2022 as against Rs 104.48 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 101.52 | 104.48 | -3 |
| OPM % | 16.08 | 6.79 | – |
| PBDT | 22.69 | 11.97 | 90 |
| PBT | 21.31 | 9.29 | 129 |
| NP | 18.35 | 7.02 | 161 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
